Gallbladder Adenocarcinoma: CD68, CD163, PanCK, PD-L1
CD68, CD163, PanCK, PD-L1
Gallbladder Adenocarcinoma
Head & Neck Squamous Cell Carcinoma: HPV+ p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (1). Two-panel overlay, Tissue courtesy of Dr. Mark Lingen, University of Chicago.
HPV+ p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (1)
Head & Neck Squamous Cell Carcinoma
Head & Neck Squamous Cell Carcinoma: HPV+ p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (2). Two-panel overlay, Tissue courtesy of Dr. Mark Lingen, University of Chicago.
HPV+ p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (2)
Head & Neck Squamous Cell Carcinoma
Head & Neck Squamous Cell Carcinoma: HPV- p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (1). Two-panel overlay, Tissue courtesy of Dr. Mark Lingen, University of Chicago.
HPV- p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (1)
Head & Neck Squamous Cell Carcinoma
Head & Neck Squamous Cell Carcinoma: HPV- p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (2). Two-panel overlay, Tissue courtesy of Dr. Mark Lingen, University of Chicago.
HPV- p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (2)
Head & Neck Squamous Cell Carcinoma
Head & Neck Squamous Cell Carcinoma: HPV- p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (3). Two-panel overlay, Tissue courtesy of Dr. Mark Lingen, University of Chicago.
HPV- p16, CK5, EGFR, Vimentin, CD3, CD4, CD8, CD20 (3)
Head & Neck Squamous Cell Carcinoma
Head & Neck Squamous Cell Carcinoma: PD-L1, PanCK. Tissue courtesy of Dr. Mark Lingen, University of Chicago.
PD-L1, PanCK
Head & Neck Squamous Cell Carcinoma
Head & Neck Squamous Cell Carcinoma: CD4, CD8, PD-1, PanCK. Tissue courtesy of Dr. Mark Lingen, University of Chicago.
CD4, CD8, PD-1, PanCK
Head & Neck Squamous Cell Carcinoma
Head & Neck Squamous Cell Carcinoma: CD68, CD163, PanCK, PD-L1 (1). Tissue courtesy of Dr. Mark Lingen, University of Chicago.
CD68, CD163, PanCK, PD-L1 (1)
Head & Neck Squamous Cell Carcinoma
Head & Neck Squamous Cell Carcinoma: CD68, CD163, PanCK, PD-L1 (2). Tissue courtesy of Dr. Mark Lingen, University of Chicago.
CD68, CD163, PanCK, PD-L1 (2)
Head & Neck Squamous Cell Carcinoma
Luminal B Breast Cancer: CD4, CD8, FoxP3, Tbet
CD4, CD8, FoxP3, Tbet
Luminal B Breast Cancer
Luminal B Breast Cancer: HER2, ER, PR, Ki-67, CD3, CD4, CD8. Two-panel overlay.
HER2, ER, PR, Ki-67, CD3, CD4, CD8
Luminal B Breast Cancer
Luminal B Breast Cancer: HER2, ER, PR, Ki-67
HER2, ER, PR, Ki-67
Luminal B Breast Cancer
Lung Adenocarcinoma: CD68, CD163, PanCK, PD-L1
CD68, CD163, PanCK, PD-L1
Lung Adenocarcinoma
Pancreatic Ductal Adenocarcinoma: CK5, Vimentin, EGFR, Ki-67
CK5, Vimentin, EGFR, Ki-67
Pancreatic Ductal Adenocarcinoma
Stomach Adenocarcinoma: CD4, CD8, FoxP3, PD-1
CD4, CD8, FoxP3, PD-1
Stomach Adenocarcinoma
Thyroid Gland Papillary Carcinoma: CD4, CD8, FoxP3, PD-1
CD4, CD8, FoxP3, PD-1
Thyroid Gland Papillary Carcinoma
Thyroid Gland Papillary Carcinoma: CD68, CD163, PanCK, PD-L1
CD68, CD163, PanCK, PD-L1
Thyroid Gland Papillary Carcinoma
Triple-Negative Breast Cancer: CD4, CD8, FoxP3, Tbet
CD4, CD8, FoxP3, Tbet
Triple-Negative Breast Cancer
Triple-Negative Breast Cancer: Ki-67, CD8, CD4, CD31 20x
Ki-67, CD8, CD4, CD31 20x
Triple-Negative Breast Cancer
Triple-Negative Breast Cancer: Ki-67, CD8, CD4, CD31 5x
Ki-67, CD8, CD4, CD31 5x
Triple-Negative Breast Cancer
Triple Negative Breast Cancer: CD3, CD20, PD-L1, CK5
CD3, CD20, PD-L1, CK5
Triple Negative Breast Cancer
Triple Negative Breast Cancer: EGFR, Vimentin, CK5, Ki-67, CD3, CD4, CD8. Two-panel overlay.
EGFR, Vimentin, CK5, Ki-67, CD3, CD4, CD8
Triple Negative Breast Cancer
Triple Negative Breast Cancer: EGFR, CK5, Ki-67, CD3, CD4, CD8, CD20. Two-panel overlay.
EGFR, CK5, Ki-67, CD3, CD4, CD8, CD20
Triple Negative Breast Cancer
Uterine Cervix Squamous Cell Carcinoma: CD68, CD163, PanCK, PD-L1
CD68, CD163, PanCK, PD-L1
Uterine Cervix Squamous Cell Carcinoma

Your cart

Total
USD
Shipping and discount codes are added at checkout.